168 related articles for article (PubMed ID: 37882489)
1. Liquid biopsies in thyroid cancers: a systematic review and meta-analysis.
Zeyghami W; Hansen MU; Jakobsen KK; Groenhøj C; Feldt-Rasmussen U; von Buchwald C; Hahn CH
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37882489
[TBL] [Abstract][Full Text] [Related]
2. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC
BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526
[TBL] [Abstract][Full Text] [Related]
3. Plasma cell-free DNA integrity plus circulating tumor cells: a potential biomarker of no distant metastasis breast cancer.
Wang W; Liang M; Ma G; Li L; Zhou W; Xia T; Xie H; Wang S
Neoplasma; 2017; 64(4):611-618. PubMed ID: 28485169
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.
Zhu Y; Zhang H; Chen N; Hao J; Jin H; Ma X
Medicine (Baltimore); 2020 Jan; 99(3):e18581. PubMed ID: 32011436
[TBL] [Abstract][Full Text] [Related]
5. Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer.
Romano C; Martorana F; Pennisi MS; Stella S; Massimino M; Tirrò E; Vitale SR; Di Gregorio S; Puma A; Tomarchio C; Manzella L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299334
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Role of Cell-free DNA Integrity in Thyroid Cancer Particularly for Bethesda IV Cytology.
Higazi AM; El Hini SH; El-Sharkawy EA; Gayyed MF; Aziz NA; Matta RA
Endocr Pract; 2021 Jul; 27(7):673-681. PubMed ID: 33601025
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
8. Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer.
Xu JY; Handy B; Michaelis CL; Waguespack SG; Hu MI; Busaidy N; Jimenez C; Cabanillas ME; Fritsche HA; Cote GJ; Sherman SI
J Clin Endocrinol Metab; 2016 Nov; 101(11):4461-4467. PubMed ID: 27575943
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis.
Hou F; Sun XD; Deng ZY
Medicine (Baltimore); 2023 Feb; 102(7):e32928. PubMed ID: 36800605
[TBL] [Abstract][Full Text] [Related]
11. Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer.
Rossi G; Mu Z; Rademaker AW; Austin LK; Strickland KS; Costa RLB; Nagy RJ; Zagonel V; Taxter TJ; Behdad A; Wehbe FH; Platanias LC; Gradishar WJ; Cristofanilli M
Clin Cancer Res; 2018 Feb; 24(3):560-568. PubMed ID: 29180605
[No Abstract] [Full Text] [Related]
12. Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review.
Cheng J; Tang Q; Cao X; Burwinkel B
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1595-1602. PubMed ID: 28830871
[No Abstract] [Full Text] [Related]
13. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
14. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements.
Tuaeva NO; Falzone L; Porozov YB; Nosyrev AE; Trukhan VM; Kovatsi L; Spandidos DA; Drakoulis N; Kalogeraki A; Mamoulakis C; Tzanakakis G; Libra M; Tsatsakis A
Cells; 2019 Oct; 8(10):. PubMed ID: 31615102
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients.
Weng X; YangYang ; Cai Y
Dis Markers; 2022; 2022():5188006. PubMed ID: 35140820
[TBL] [Abstract][Full Text] [Related]
16. CTC, ctDNA, and Exosome in Thyroid Cancers: A Review.
Wang W; Zheng Z; Lei J
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762070
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
Nordgård O; Tjensvoll K; Gilje B; Søreide K
Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
[TBL] [Abstract][Full Text] [Related]
18. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
Tan Y; Wu H
Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
[TBL] [Abstract][Full Text] [Related]
19. A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs.
Xie J; Hu B; Gong Y; He S; Lin J; Huang Q; Cheng J
J Transl Med; 2023 Dec; 21(1):873. PubMed ID: 38041139
[TBL] [Abstract][Full Text] [Related]
20. Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer.
Moon SM; Kim JH; Kim SK; Kim S; Kwon HJ; Bae JS; Lee S; Lee HS; Choi MY; Jeon BH; Jeong BH; Lee K; Kim HK; Kim J; Um SW
Anticancer Res; 2020 Jun; 40(6):3435-3444. PubMed ID: 32487642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
